,,iv  #aag? ,,congress  #b;d ,session   
,h4 ,,res4 #hgf  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,janu>y #ai1 #bjbb,mr4
 ,burgess submitt$ ! foll[+ resolution2 
:i* 0 ref]r$ to ! ,committee on ,en]gy &
 ,comm]ce  ,,resolution  ,express+ !    
s5se t ! process beh9d ,op]ation ,w>p   
,spe$ %\ld be integrat$ )9 op]ations at 
! ,food & ,drug ,adm9i/ration4  ,t x is 
! s5se ( ,congress t ! ,commission] (   
,food & ,drugs %\ld-- 7#a7 to ! ext5t   
sci5tifically & legally possible1       
integrate ! process beh9d ,op]ation ,w>p
 ,spe$ into op]ations at ! ,food & ,drug
 ,adm9i/ration2  7#b7 issue guidance    
id5tify+ ways t drug & biological       
product innovation & developm5t c be    
accel]at$ ?r\gh cl9ical trials & !      
approval & lic5sure processes2  7#c7 =  
purposes ( accel]at+ ! approval ( new   
drugs & biological products1            
cross-ref]5ce applicable safety &       
sci5tific data f approv$ drugs & lic5s$ 
biological products2 &  7#d7 collect    
int]im data t w\ld all[ = p>allel       

assessm5ts ( ! safety & effectiv5ess (  
multiple drugs & biological products & !
 p>allel approval or lic5sure ( multiple
 drugs & biological products1 includ+   
?r\gh ! conduct ( concurr5t cl9ical     
trials4